Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
SHSE:603102's PEG Ratio is ranked worse than 82.15% of 790
companies
in the Consumer Packaged Goods industry
Industry Median: 1.28
vs SHSE:603102: 4.98
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Weihai Baihe Biology Technological Co (SHSE:603102) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Weihai Baihe Biology Technological Co PEG Ratio Related Terms
Weihai Baihe Biology Technological Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Weihai Baihe Biology Technological Co PEG Ratio Chart
For the Packaged Foods subindustry, Weihai Baihe Biology Technological Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Weihai Baihe Biology Technological Co PEG Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Weihai Baihe Biology Technological Co's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Weihai Baihe Biology Technological Co's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Weihai Baihe Biology Technological Co (SHSE:603102) has a PEG Ratio of 4.98 as of Jul. 27, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Weihai Baihe Biology Technological Co and its competitors. This is 248% above median its historical median of 1.43. Over the past decade, Weihai Baihe Biology Technological Co's PEG Ratio has ranged from 0.69 to 6.24. According to the industry distribution chart, Weihai Baihe Biology Technological Co ranks #649 out of 790 companies in the Consumer Packaged Goods industry, placing it in the top 82.2%.
Is Weihai Baihe Biology Technological Co's PEG Ratio too high?
Weihai Baihe Biology Technological Co's current PEG Ratio of 4.98 is 248% above median its 10-year median of 1.43. Over the past 10 years, this metric has ranged from a low of 0.69 to a high of 6.24. The Consumer Packaged Goods industry median PEG Ratio is 1.28. Weihai Baihe Biology Technological Co's value of 4.98 is 289.1% above this industry median. Based on the distribution chart, Weihai Baihe Biology Technological Co ranks #649 out of 790 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Weihai Baihe Biology Technological Co has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Weihai Baihe Biology Technological Co's PEG Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Weihai Baihe Biology Technological Co ranks #649 out of 790 companies for PEG Ratio. This places Weihai Baihe Biology Technological Co in the lower half of its industry. The industry median PEG Ratio is 1.28. Weihai Baihe Biology Technological Co's value of 4.98 is 289.1% above this benchmark. Historically, Weihai Baihe Biology Technological Co's own PEG Ratio has ranged from 0.69 to 6.24 over the past decade. While the company's 10-year median is 1.43 vs. the industry median of 1.28, Weihai Baihe Biology Technological Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Consumer Packaged Goods company?
The median PEG Ratio among Consumer Packaged Goods companies is 1.28, based on 790 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Weihai Baihe Biology Technological Co's current PEG Ratio of 4.98 is 289.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Weihai Baihe Biology Technological Co and its competitors. For the Consumer Packaged Goods industry, the median PEG Ratio is 1.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Weihai Baihe Biology Technological Co's current PEG Ratio is 4.98, which is 248% above median its own 10-year median of 1.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Weihai Baihe Biology Technological Co stock overvalued right now?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co (SHSE:603102) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥48.82, compared to a current price of ¥31.30 — trading 35.9% below its estimated fair value. The current PEG Ratio is 4.98, which is 248% above median its 10-year median of 1.43 and 289.1% above the Consumer Packaged Goods industry median of 1.28. Weihai Baihe Biology Technological Co's overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Weihai Baihe Biology Technological Co (SHSE:603102), the current PEG Ratio is 4.98 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Weihai Baihe Biology Technological Co (SHSE:603102) Overvalued in 2026?
Based on GuruFocus' analysis, Weihai Baihe Biology Technological Co stock appears to be undervalued.
The current stock price of ¥31.30 is trading 35.9% below its estimated GF Value™ of ¥48.82.
GuruFocus considers Weihai Baihe Biology Technological Co to be Significantly Undervalued.
Key valuation signals for SHSE:603102:
PEG Ratio: 4.98 (248% above median its 10-year median of 1.43)
GF Value™: ¥48.82 vs. price of ¥31.30 (35.9% below fair value)
Industry Position: 289.1% above the Consumer Packaged Goods median (#649 of 790)
No single metric tells the full story. See the SHSE:603102 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Weihai Baihe Biology Technological Co Business Description
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603102 has been successfully added to your 
